Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Dana Michalska"'
Autor:
Dana Michalska, Vit Zikan
Publikováno v:
Endocrine Abstracts.
Autor:
David B. Burr, Fernando Marin, Harald Dobnig, Jiliang Li, Jan J. Stepan, Astrid Fahrleitner-Pammer, Yanfei L. Ma, Dana Michalska, Qing Q. Zeng, Alan Y. Chiang, Imre Pavo
Publikováno v:
Bone. 59:139-147
article i nfo Cortical bone, the dominant component of the human skeleton by volume, plays a key role in protecting bones from fracture. We analyzed the cortical bone effects of teriparatide treatment in postmenopausal women with osteoporosis who had
Publikováno v:
European Journal of Endocrinology. 164:643-648
BackgroundWe hypothesized that with the administration of teriparatide (TPTD) treatment at different times, we would be able to modify the physiological circadian rhythm of bone turnover.MethodsThe concentration of serum C-terminal telopeptide of col
Autor:
Jiliang Li, Jan J. Stepan, Imre Pavo, Adrien Sipos, Helmut Petto, Astrid Fahrleitner-Pammer, Michael Westmore, Masahiko Sato, David Michalsky, David B. Burr, Harald Dobnig, Dana Michalska
Publikováno v:
Bone. 41:378-385
Marked suppression of bone turnover by bisphosphonates is associated with increased bone microdamage accumulation in animal models. The purpose of this study was to test the hypothesis that long-term treatment with alendronate (ALN) results in accumu
Publikováno v:
Calcified Tissue International. 76:98-106
To compare the ability of the bone mineral density (BMD) at the distal forearm, collagen I alpha 1 (COLIA1) polymorphism, and ultrasound stiffness to identify individuals with increased risk of wrist fracture, we studied 183 postmenopausal Czech wome
Publikováno v:
Bone Abstracts.
Autor:
Harald Dobnig, Yanfei L. Ma, Astrid Fahrleitner-Pammer, Imre Pavo, David B. Burr, Helmut Petto, Dana Michalska, Adrien Sipos, Jiliang Li, Jan J. Stepan
Publikováno v:
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 21(12)
The level of increased bone formation after 24 months of treatment with teriparatide (rhPTH (1–34), TPTD) is similar in patients who were either treatment-naive (TN) or had lower bone turnover initially due to previous alendronate (ALN) therapy. Bo
Publikováno v:
The Journal of clinical endocrinology and metabolism. 91(3)
The aim of this study was to compare bone mineral density (BMD) and biochemical markers of bone turnover in patients receiving long-term alendronate therapy who continued alendronate, were switched to raloxifene, or discontinued antiresorptive therap
Publikováno v:
Bone, 26(3), 287-290. Elsevier Inc.
Wrist fractures associated with postmenopausal women are only partially explained by osteoporosis. Recent studies have shown that polymorphism of an Sp1 binding site in the first intron of the collagen I alpha 1 gene (COLIA1) may determine risk for v
Publikováno v:
Bone. 50:S145